主记录
revumenib
- CAS
- 2169919-21-3
- PubChem CID
- 132212657
- SMILES
- CCN(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)CC
- 分子式
- C32H47FN6O4S
- 分子量
- 630.831
- 精确分子量
- 630.3364
- InChI
- InChI=1S/C32H47FN6O4S/c1-5-39(23(3)4)31(40)27-17-25(33)9-12-28(27)43-29-18-34-22-35-30(29)38-20-32(21-38)13-15-37(16-14-32)19-24-7-10-26(11-8-24)36-44(41,42)6-2/h9,12,17-18,22-24,26,36H,5-8,10-11,13-16,19-21H2,1-4H3
- InChIKey
- FRVSRBKUQZKTOW-UHFFFAOYSA-N
- LogP
- 4.6788
- TPSA
- 107.97
名称与别名
- revumenib
- SNDX-5613
- Revuforj
- 2169919-21-3
- Revumenib [WHO-DD]
- REVUMENIB [INN]
- Revumenib (USAN/INN)
- REVUMENIB [USAN]
- LZ0M43NNF2
- SNDX5613 FREE BASE
- UNII-LZ0M43NNF2
- SNDX5613
- SNDX-5613 FREE BASE
- SNDX50613 FREE BASE
- SNDX-50613 FREE BASE
- orb1089371
- orb1309080
- CHEMBL4650827
- SCHEMBL19693219
- SCHEMBL19693428
- SCHEMBL24710933
- SCHEMBL30406445
- GTPL11882
- SNDX50613
- DTXSID301385187
- GLXC-26408
- SNDX-50613
- SNDX-5613?
- EX-A4343
- ULD91921